drugset / Trial / NCT00225667

Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

NCT00225667

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine whether irbesartan will reduce the rate of recurrent atrial high rate episodes and the development of clinical sustained atrial fibrillation in patients with hypertension and permanent pacemaker.

Timeline

Start
2005-12
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Irbesartan Small molecule